Ikarian Capital, LLC - 31 Jan 2026 SCHEDULE 13G/A Report for Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share (QNRX)

Filing Manager
Ikarian Capital, LLC
Reporting Manager
Ikarian Capital, LLC
Security
Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share
Symbol
QNRX
Shares outstanding
1,678,873 shares
Disclosed Ownership
211,538 shares
Ownership
13%
Form type
SCHEDULE 13G/A
Filing time
06 Feb 2026, 17:28:48 UTC
Date of event
31 Jan 2026
Previous filing
15 Dec 2025
SEC
View on sec.gov

Quoteable Key Fact

"Ikarian Capital, LLC disclosed 13% ownership in Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share (QNRX) on 31 Jan 2026."

Quick Takeaways

  • Ikarian Capital, LLC filed SCHEDULE 13G/A for Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share (QNRX).
  • Disclosed ownership: 13%.
  • Date of event: 31 Jan 2026.

What Changed

  • Previous schedule filing date: 15 Dec 2025.
  • Current filing was accepted on 06 Feb 2026, 17:28.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Ikarian Capital, LLC 13% 211,538 0 211,538 /s/ Neil Shahrestani Neil Shahrestani, Sole Manager
Neil Shahrestani 13% 211,538 0 211,538 /s/ Neil Shahrestani Neil Shahrestani
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .